Abstract: A vehicle remote control system includes a vehicle. The vehicle remote control system includes: a control unit that starts a change of a state of the vehicle to a predetermined state when a predetermined start condition is satisfied; a calculation unit that calculates an estimated required period required to change to reach the predetermined state; and a notification unit that notifies, to a user, estimation information about the calculated estimated required period. The user can be notified of the period required for the state of the vehicle to change to reach the predetermined state.

Abstract: This information processing system processes information through communication between a first information processing device and a second information processing device. The second information processing device has a recording unit and a control unit. The recording unit records a first OS and a second OS. The control unit selects one of the first OS and the second OS, according to a connection state with the first information processing device. The control unit controls the second information processing device or a combination of the first information processing device and the second information processing device, using the OS selected here.

Abstract: The present invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof:

Abstract: The present invention provides: a compound represented by the following formula (I): [wherein Y1 and Y4 represent a hydrogen atom or a halogen atom; either one of Y2 and Y3 represents —NR1R2, and the other represents a hydrogen atom or a halogen atom; X represents an aryl group or a heteroaryl group that may be substituted; R1 represents a hydrogen atom, or a C1-8 alkyl group that may be substituted; and R2 represents a C1-8 alkyl group that is substituted with one or more substituents, —COOR3, —COR4, —COSR5, —CONR6R7, —NR22R23, or —C?NR24R25; or R1 and R2, together with a nitrogen atom to which they are bonded, may form a 4- to 10-membered hetero ring containing at least one nitrogen atom (wherein the hetero ring may be substituted with one or more substituents selected from Group C)], a prodrug thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical, a pharmaceutical composition, or the like, which comprises the compound.

Abstract: The present invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof:

Abstract: The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.

Abstract: The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.

Abstract: The present invention provides: a compound represented by the following formula (I): [wherein Y1 and Y4 represent a hydrogen atom or a halogen atom; either one of Y2 and Y3 represents —NR1R2, and the other represents a hydrogen atom or a halogen atom; X represents an aryl group or a heteroaryl group that may be substituted; R1 represents a hydrogen atom, or a C1-8 alkyl group that may be substituted; and R2 represents a C1-8 alkyl group that is substituted with one or more substituents, —COOR3, —COR4, —COSR5, —CONR6R7, —NR22R23, or —C?NR24R25; or R1 and R2, together with a nitrogen atom to which they are bonded, may form a 4- to 10-membered hetero ring containing at least one nitrogen atom (wherein the hetero ring may be substituted with one or more substituents selected from Group C)], a prodrug thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical, a pharmaceutical composition, or the like, which comprises the compound.

Abstract: A projection display apparatus for expanding and projecting an image, which is formed by an optical modulator, using a projection lens. A light source illuminates the optical modulator. A first lens array divides light emitted from the light source into a plurality of partial luminous fluxes. A second lens array superimposes the plurality of partial luminous fluxes emitted from the first lens array onto the optical modulator. A diaphragm mechanism is disposed between the light source and the optical modulator, and controls an amount of light from the light source. A traveling direction of the light emitted from the light source is defined as a Z-axis, a direction perpendicular to the Z-axis is defined as an X-axis, and a direction perpendicular to a plane formed by the Z-axis and the X-axis is defined as a Y-axis. An area of an opening of the diaphragm mechanism changes in a direction of the X-axis or the Y-axis.

Abstract: With a trend toward a higher intensity projection type liquid crystal display device to further increase brightness of a projection screen, rated input power of a light source lamp increases, which makes essential a fan apparatus for cooling the light source lamp, etc. Such a fan apparatus would require a light-shielding member which causes the number of parts to increase. The present invention provides a fan apparatus provided with a rotor section that can be rotated/driven around a predetermined rotation axis and a propeller section including propeller blades and attached to the rotor section arranged in such a way as to substantially shield light parallel to the rotation axis.

Abstract: A projection display apparatus for expanding and projecting an image, which is formed by an optical modulator, using a projection lens. A light source illuminates the optical modulator. A first lens array divides light emitted from the light source into a plurality of partial luminous fluxes. A second lens array superimposes the plurality of partial luminous fluxes emitted from the first lens array onto the optical modulator. A diaphragm mechanism is disposed between the light source and the optical modulator, and controls an amount of light from the light source. A traveling direction of the light emitted from the light source is defined as a Z-axis, a direction perpendicular to the Z-axis is defined as an X-axis, and a direction perpendicular to a plane formed by the Z-axis and the X-axis is defined as a Y-axis. An area of an opening of the diaphragm mechanism changes in a direction of the X-axis or the Y-axis.

Abstract: The present invention relates to novel Aerothricins represented by the Formula (I), and pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising an Aerothricin of the Formula (I) and a pharmaceutically acceptable carrier. Furthermore, the present invention relates to the use of such Aerothricins for the preparation of medicaments, as well as to processes for the preparation of the Aerothricins of the Formula (I).

Abstract: A liquid crystal display (LCD) projector in which temperature rise of the polarizing plate is reduced and the liquid crystal display panels and polarizing plates are easily retained in place. In the LCD projector, at least one of the incident light side polarizing plate and the exit light side polarizing plate has a first polarizing plate disposed on the incident light side of a glass substrate and a second polarizing plate disposed on the exit light side of the glass substrate. The first polarizing plate has a low degree of polarization and the second polarizing plate has a high degree of polarization and the polarizing plates are arranged to have their axes of transmission polarization coincident. The temperature rise due to absorption of light is shared by the first and second polarizing plates and this contributes to reduction in size of the projector.

Abstract: Novel anti-tumor compounds of formula, are disclosed. Also disclosed are pharmaceutical compositions comprising compounds of formula (I), the use of compounds of formula (I) for the treatment of cancer, and processes for the preparation of compounds (I).

Abstract: With a trend toward a higher intensity projection type liquid crystal display device to further increase brightness of a projection screen, rated input power of a light source lamp increases, which makes essential a fan apparatus for cooling the light source lamp, etc. Such a fan apparatus would require a light-shielding member which causes the number of parts to increase. The present invention provides a fan apparatus provided with a rotor section 410 that can be rotated/driven around a predetermined rotation axis and a propeller section 420 including propeller blades 421 to 428 and attached to the rotor section 410 arranged in such a way as to substantially shield light parallel to the rotation axis.

Abstract: Novel anti-tumor compounds of formula, 1

Abstract: A light source, a color separator, a plurality of liquid crystal panels, a polarizing plate, a color synthesizing optical unit, and a projecting lens are disposed. The color synthesizing optical unit includes an X prism, a bonding base, a panel retaining member, and a panel installing member. The panel retaining member is fixed on the bonding base. The liquid crystal panels and the polarizing plate are installed on the panel installing member. The panel installing member can be separated from the panel retaining member. By this configuration, deviation of the convergence can be prevented with respect to the liquid crystal panels. Further, in practical use, it is easy to replace or repair the liquid crystal panel or the polarizing plate.

Abstract: The present invention relates to novel Aerothricins represented by the Formula (I), wherein R1, R2, R3, R4, R5, X, Y, Z, and m are as defined in Claim 1; and pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising an Aerothricin of the Formula (I) and a pharmaceutically acceptable carrier. Furthermore, the present invention relates to the use of such Aerothricins for the preparation of medicaments, as well as to processes and intermediates for the preparation of the Aerothricins of the Formula (I).

Abstract: A liquid crystal display (LCD) projector in which temperature rise of the polarizing plate is reduced and the liquid crystal display panels and polarizing plates are easily retained in place. In the LCD projector, at least one of the incident light side polarizing plate and the exit light side polarizing plate has a first polarizing plate disposed on the incident light side of a glass substrate and a second polarizing plate disposed on the exit light side of the glass substrate. The first polarizing plate has a low degree of polarization and the second polarizing plate has a high degree of polarization and the polarizing plates are arranged to have their axes of transmission polarization coincident. The temperature rise due to absorption of light is shared by the first and second polarizing plates and this contributes to reduction in size of the projector.

Abstract: A projector that can project a picture up and down on a screen free from the trapezium deformation, and allows the projection lens to be exchanged with other projection lens by an easy operation from outside of the front panel, without necessitating dismounting of any of the internal structure of projection apparatus. Projection lens shifts its standing up and down in accordance with revolving of a revolving knob disposed on the upper part of the projection apparatus. For the exchange of projection lens, a projection lens can be unscrewed and detached from the outer cylindrical section 9-2 of lens holding member 9 by turning the inner barrel 8 from outside the cabinet at the front.